fda tirzepatide shortage resolved 2025 Announced Removal of from the Drug List Out of Shortage, Into Controversy:
Description
While Semaglutide only targets the GLP-1 hormone, Tirzepatide affects both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) hormones

Your healthcare provider can help guide you if youre having trouble staying on schedule with Zepbound
If you added 2 mL to a 10 mg vial instead of 1 mL, your concentration is now 5 mg/mL instead of 10 mg/mL

But the data does allow us to create decision frameworks

Research-context information only
[42] At the GLP-1 receptor, though, tirzepatide shows bias toward cAMP (a messenger associated with regulation of glycogen, sugar, and lipid metabolism) generation rather than -arrestin recruitment